The AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
Read the Statement
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreThe AACR Cancer Disparities Progress Report 2026 is available. The report provides an overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Read the ReportMore than 67,500 people in the United States are expected to be diagnosed with pancreatic cancer last year. Learn about the treatment options for this type of cancer.
Learn MoreMikey Shock was pursuing a degree focused on understanding and supporting queer and transgender communities when a cancer diagnosis confirmed the need for affirming and culturally competent care.
Read Mikey’s StoryUseful information for cancer patients and their families, survivors, caregivers, advocates, and others from Cancer Today magazine.
Learn MoreWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSession recordings are available for viewing to registered attendees through October 31. Registration remains open for the on-demand virtual meeting.
The AACR Cancer Disparities Progress Report 2026 provides a comprehensive overview of the latest research on cancer disparities and calls for policies to reduce disparities and achieve cancer health equity.
Learn MoreThe AACR and its more than 61,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreThe AACR Pediatric Cancer Progress Report 2025 highlights the remarkable progress against childhood cancers driven by discoveries across the basic, translational, clinical, and population sciences.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2023
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2024, to June 30, 2025
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn More